Log in to your Inderes Free account to see all free content on this page.
Paxman
48.35 SEK
-1.33 %
Less than 1K followers
PAX
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-1.33 %
+3.98 %
+5.80 %
-13.97 %
-26.96 %
-36.04 %
+46.52 %
-17.49 %
+343.58 %
Paxman is active in scalp cooling, which is used for patients undergoing chemotherapy. The company's product Paxman Scalp Cooler is used to minimize hair loss in patients during treatment. The Scalp Cooler is a freestanding, mobile and electrically powered cooling unit that cools the patient's scalp via a cooling cap. Paxman was founded in 1996 and is headquartered in Karlshamn.
Read moreMarket cap
1.13B SEK
Turnover
495.1K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
21.5.
2026
Interim report Q1'26
22.5.
2026
General meeting '26
21.8.
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
Paxman publishes the company’s annual report for 2025
NOTICE OF ANNUAL GENERAL MEETING IN PAXMAN AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio